Indeed, this mechanism is due to the activation of Wnt/beta-catenin signaling, which results in elevating immune-regulatory molecules expression, particularly IL-10 in the tumor microenvironment dendritic cells[53]. The gene discussed is CTNNB1; the disease is neoplasm.